The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT05624749
Brief Title: Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2) (SIRIUS-SLE 2)

First Submitted : November 7, 2022
First Submitted that Met QC Criteria : November 21, 2022
First Posted : November 22, 2022

Last Update Submitted that Met QC Criteria : May 17, 2024
Last Update Posted : May 20, 2024